Naples, Italy

Matteo Di Minno

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Bioviiix S.r.l.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matteo Di Minno. Retrieved from https://idiyas.com/inventor/matteo-di-minno

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matteo Di Minno: Innovator in Nanoparticle Delivery Systems

Introduction

Matteo Di Minno is a prominent inventor based in Naples, Italy. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative delivery systems for cancer treatment.

Latest Patents

Matteo holds a patent for "Nanoparticles, composition and system for delivering 5FU and uses thereof." This invention focuses on nanoparticles of albumin loaded with 5FU and/or its precursors. The patent outlines a pharmaceutical composition or delivery system that utilizes these nanoparticles, emphasizing their potential as a medicament for tumor treatment.

Career Highlights

Matteo Di Minno is associated with Bioviiix S.r.l., where he applies his expertise in nanoparticle technology. His work is pivotal in advancing therapeutic options for patients suffering from cancer.

Collaborations

Matteo collaborates with notable colleagues, including Salvatore Asero and Roberta Lupoli, who contribute to the innovative projects at Bioviiix S.r.l.

Conclusion

Matteo Di Minno's work in nanoparticle delivery systems represents a significant advancement in cancer treatment methodologies. His innovative approach has the potential to improve therapeutic outcomes for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…